Search Results Search Sort by RelevanceMost Recent AMA Code Says Sep 2021 AMA Code of Medical Ethics’ Opinions Related to Implantable Devices Robert Dinallo The AMA Code of Medical Ethics offers guidance for balancing need for safety with demand for innovation. AMA J Ethics. 2021; 23(9):E702-704. doi: 10.1001/amajethics.2021.702. Medicine and Society Aug 2022 Clinicians’ Racial Biases as Pathways to Iatrogenic Harms for Black People Keisha Ray, PhD Clinicians’ racial biases undermine the quality of Black persons’ health care experiences and pave a reliable path to health care-induced harm. AMA J Ethics. 2022; 24(8):E768-772. doi: 10.1001/amajethics.2022.768. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004; 6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004; 6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
AMA Code Says Sep 2021 AMA Code of Medical Ethics’ Opinions Related to Implantable Devices Robert Dinallo The AMA Code of Medical Ethics offers guidance for balancing need for safety with demand for innovation. AMA J Ethics. 2021; 23(9):E702-704. doi: 10.1001/amajethics.2021.702.
Medicine and Society Aug 2022 Clinicians’ Racial Biases as Pathways to Iatrogenic Harms for Black People Keisha Ray, PhD Clinicians’ racial biases undermine the quality of Black persons’ health care experiences and pave a reliable path to health care-induced harm. AMA J Ethics. 2022; 24(8):E768-772. doi: 10.1001/amajethics.2022.768.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004; 6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004; 6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
